The Department of Health and Human Services plans to cancel contracts and pull funding for some vaccines being developed to ...

Trump administration's Health and Human Services Department cancels 22 mRNA vaccine contracts totaling roughly $500 million, ...

CAMBRIDGE, MA / ACCESS Newswire / July 30, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission ...

The U.S. Department of Health and Human Services said on Tuesday it would wind down mRNA vaccine development activities under its biomedical research unit.

Second quarter earnings season is in full swing, and the results have been largely positive so far, with more positive ...

Moderna faces weak post-pandemic vaccine demand and financial struggles, with limited near-term catalysts. Click here to read ...

The tide is turning in America’s COVID policy, with the recent announcement that the federal government will no longer recommend booster shots for most healthy Americans under the age of 65. This ...

In a small trial across ten U.S. research sites, a novel HIV vaccine candidate has shown a result that has eluded scientists ...

Vinay Prasad is leaving Sensible Medicine to take a senior role at the US FDA. He has our enthusiastic support. Prasad is ...

CAMBRIDGE, MA / ACCESS Newswire / August 1, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal ...

SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the ...

The researchers followed participants from October 2024 to January 2025. Median age was 76 years, and 54.2% were women. By ...